Disys

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Disys

What is Disys? Identity and Action Principles

Disys is a highly selective, prescription-only medication used to manage blood pressure and certain heart conditions. Its identity is defined by its active ingredient and its specific pharmacological action.

Property Description
Active ingredient Valsartan
Form Tablet and Oral Suspension
Pharmacological class Angiotensin II Receptor Blocker (ARB)
Common use Managing high blood pressure
Origin Synthetic Compound

Identity and Pharmacological Classification

The medication Disys is an oral medication whose primary component is Valsartan, classifying it strictly as an Angiotensin II Receptor Blocker (ARB). The ARB class represents a major grouping of antihypertensive agents used globally. This indicates that the medicine is primarily used to stabilize and reduce persistently elevated blood pressure.

Valsartan is a synthetic compound that operates by selectively blocking the action of Angiotensin II, a hormone responsible for constricting blood vessels. The efficacy and safety profile of Valsartan are established for the treatment of hypertension and heart failure. This means that the drug is a clinically recognized treatment option to reduce cardiovascular system stress, distinguishing it as an established tool for long-term pressure management.


Forms and General Therapeutic Purpose

Disys is notably available in two primary dosage forms: a solid tablet and an oral suspension (liquid), both intended for oral administration. The oral suspension form differentiates its presentation by offering a liquid option for certain patient groups, such as children (aged 1 year and older) or those who experience difficulty swallowing tablets. The composition is centered on Valsartan as a single-entity product.

The overall general purpose of this therapy is to induce a vessel-widening (vasodilatory) effect, which lowers the pressure within the arteries. By achieving this, Disys provides the essential benefit of reducing the workload on the heart, a typical use scenario in managing high blood pressure and supporting function in specific heart conditions.

What side effects are possible with Disys?

Possible Side Effects and Safety Information

The officially documented safety profile of Disys (Valsartan), an Angiotensin II Receptor Blocker, is defined by adverse reactions classified by frequency and the organ systems affected, as stated in government regulatory documents.

Adverse Reaction Classification

The most frequently observed adverse reactions in clinical trials are classified as common. These typically include dizziness, headache, hypotension (low blood pressure), fatigue, and hyperkalemia (increased potassium levels in the blood). Less common effects are also documented.

Adverse effects are categorized by the physiological systems involved, including the Vascular system, Nervous System, Metabolism and Nutrition (related to electrolyte balance), and Renal and Urinary systems, consistent with the drug’s pharmacological class.

Classification Examples of Documented Adverse Reactions
Common Headache, Dizziness, Hypotension, Hyperkalemia
Not Known Angioedema, Renal Failure, Thrombocytopenia

Serious Safety Concerns and Restrictions

Official regulatory labeling highlights certain serious adverse reactions. The most critical safety constraint is the Fetal Toxicity warning; use of Disys during the second and third trimesters of pregnancy can cause injury or death to the developing fetus. Additionally, rare but serious reactions documented in post-marketing experience include Angioedema (swelling of the face, lips, or throat) and the potential for Renal Failure.

Safety limitations also apply to specific patient groups. Disys is contraindicated in patients with severe hepatic impairment, and its use is restricted for patients with diabetes who are also taking aliskiren. Regulatory documents note that hypotension may be particularly apparent at the initiation of therapy in certain volume-depleted individuals.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose information for Disys (Valsartan) focuses on the physiological consequences of excessive therapeutic action and the necessary emergency response to severe manifestations, strictly according to regulatory labeling.

Feature Official Regulatory Statement
Documented Overdose Presentations Primarily presents as an exaggerated pharmacological effect, leading to marked hypotension (low blood pressure), associated with symptoms such as extreme dizziness, fainting, and heartbeat irregularities (fast or slow heart rate).
Physiological Systems Affected The official label indicates effects on the Cardiovascular system (hypotension, circulatory collapse, shock) and Central Nervous System (depressed level of consciousness).
Severity Classification Overdose can lead to life-threatening outcomes, specifically circulatory collapse and shock due to the profound drop in blood pressure.
Antidote / Removal Constraints No specific antidote is known for Valsartan overdose, and the substance is unlikely to be removed by hemodialysis due to its high plasma protein binding.

When Immediate Medical Help is Required

Seek immediate medical attention for any suspected overdose. Emergency services must be called if the individual shows severe signs such as collapse, seizure, trouble breathing, or inability to be awakened.

Management is documented as supportive and symptomatic. If marked hypotension occurs, documented procedural steps include placing the patient in the supine position and, if necessary, administering an intravenous infusion of normal saline solution to manage the effects of severe low blood pressure.

Therapeutic Uses of Disys

What Disys Treats: Main Uses and Benefits

Disys (Valsartan) is generally used for therapeutic management across core cardiovascular domains, with a focus on chronic conditions and complication risk management. Its main therapeutic purposes include addressing persistently elevated arterial pressure (hypertension), providing support for chronic heart failure, and assisting with post-heart attack support when complicated by left ventricular dysfunction.

The medication helps with the reduction of symptoms that create noticeable physiological strain and is relevant for managing symptoms associated with acute or episodic changes. Its use also may contribute to supporting organ function for high-risk groups, such as patients with Type 2 Diabetes and concurrent hypertension.

“Its application is relevant in clinical settings that involve heightened systemic burden, offering support that helps ease the overall symptom load and contributes to improved day-to-day comfort.”

Quick Fact: Support for Systemic Imbalance

Quick Fact: Support for Systemic Imbalance

The medication is commonly used to help manage symptoms linked to organ-specific functional stress, particularly in scenarios requiring supportive symptom management against symptoms related to systemic imbalance.

Eligibility and Restrictions for Use

Who Can and Cannot Use Disys? Official Regulatory Information

The eligibility for using Disys (Valsartan) is strictly defined by regulatory authorities based on age, physiological state, and existing medical conditions. The medicine is contraindicated and must not be used by certain population groups as established in official labeling.


Absolute Contraindications

Population Group Restriction Status
Pregnancy Contraindicated in the second and third trimesters; must be discontinued as soon as pregnancy is detected (first trimester).
Hypersensitivity Contraindicated in patients with a known hypersensitivity to valsartan or any product component.
Severe Organ Impairment Contraindicated in patients with severe hepatic impairment, biliary cirrhosis, or cholestasis.
Co-Therapy Contraindicated in patients with diabetes or renal impairment (GFR < 60 mL/min/1.73 m²) taking any medicine containing aliskiren.

Age and Condition Restrictions

  • Adults (18 years and older) are generally approved for all labeled uses.
  • Pediatric use is restricted to children aged 6 to 16 years for hypertension only. Use is not recommended in children under 6 years of age.
  • Nursing Mothers: Breastfeeding is not recommended, and a decision must be made to discontinue nursing or discontinue the drug.
  • Severe Renal Impairment: Use requires caution, as safety and efficacy data are limited. Use in pediatric patients with severe impairment is not recommended.

These constraints establish the mandatory boundaries for the medicine’s use, ensuring adherence to the regulatory-defined eligibility profile.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Disys (Valsartan) is primarily defined by documented risks of pharmacodynamic effects on blood pressure, electrolytes, and renal function. Formal regulatory constraints exist for co-administration with other cardiovascular agents and certain medications that alter electrolyte balance.

Documented Interaction Patterns

Interacting Agent Category Regulatory Outcome Description (Source-Aligned)
Dual Renin-Angiotensin System Blockade Contraindicated in specific patients Co-administration with Aliskiren is prohibited in patients with Diabetes Mellitus or documented Renal Impairment (GFR < 60 mL/min/1.73 m²).
Potassium-Related Agents Not Recommended / Caution Use with Potassium-sparing Diuretics or Potassium Supplements may result in hyperkalemia (elevated serum potassium levels).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Caution Co-administration may lead to deterioration of renal function and can attenuate the antihypertensive effect, particularly in patients with pre-existing renal compromise.
Lithium Caution Concomitant use has been reported to cause an increase in serum Lithium concentrations and subsequent risk of Lithium toxicity.
Food No significant effect Administration with food does not significantly affect the systemic exposure (plasma levels) to Valsartan.

Mechanism of Action

Targeting Key Kinases: Allosteric Inhibition of MEK1/2

The core molecular action of Disys involves its function as an allosteric inhibitor that binds to the enzyme MEK1/2 (Mitogen-activated protein kinase kinase 1 and 2). This engagement occurs at a site separate from the active phosphorylation region and prevents the activation of these kinases by upstream signals. This action interrupts a critical molecular step and results in changes in cellular signaling.

Modulating the RAS-RAF-MEK-ERK Signaling Pathway

Disys alters pathway activity within the RAS-RAF-MEK-ERK cascade, a critical signaling network involved in cell growth and division. By blocking MEK1/2, Disys modifies early molecular steps and suppresses signals that regulate cellular proliferation and survival, engaging a mechanism that modulates the pathway's physiological responses.

Regulating Cellular Proliferation and Apoptosis

The suppression of signaling through the MAPK cascade initiates a change in molecular signaling, influencing core mechanisms underlying its molecular activity. This ultimately leads to the physiological consequences of inhibited cell growth and the promotion of apoptosis (programmed cell death) in targeted cell populations, which is a consequence of the modulated signaling within the affected systems.

Dosage and Administration Information

How to Use Disys: Official Administration Guidelines

The administration of Disys must adhere strictly to the protocols defined in the product information. The treatment typically begins with a defined loading dose administered via intravenous (IV) infusion, followed by a transition to daily oral maintenance therapy.

Administration Scope

Field Official Labeled Instruction
Route of Administration Oral and Intravenous Infusion
Dosing Schedule Loading Dose: 200 mg (IV infusion). Maintenance Dose: 100 mg (Oral tablet) daily.
Timing in Relation to Meals Oral tablets must be taken on an empty stomach, defined as 1 hour before or 2 hours after food.
Preparation Requirements For IV use, the supplied lyophilized powder must be reconstituted with 5 mL of Sterile Water and further diluted in an appropriate infusion solution.
Age-Group Rules Adults (18+): Standard fixed-dose regimen applies. Pediatric Patients (under 18): Dosage is weight-based (e.g., 4.4 mg/kg initial dose) and must not exceed the adult maximum dose.
Missed-Dose Rules If an oral dose is missed, take it as soon as remembered. If it is nearly time for the next scheduled dose, skip the missed dose and resume the regular schedule. Do not take two doses simultaneously.
Special Procedural Conditions Oral tablets must be swallowed whole and must not be crushed, split, or chewed. IV infusion must be administered slowly over a minimum duration of 60 minutes.

Resulting Procedural Structure

The established protocols mandate a clear sequence for the initial course of therapy:

  1. Administer the 200 mg loading dose as an intravenous infusion over at least 60 minutes on Day 1.
  2. Begin the 100 mg oral maintenance dose once daily on Day 2.
  3. Ensure the oral dose is consumed on an empty stomach.

This structured approach, outlined in the prescribing protocols, standardizes the exact amount and timing of Disys throughout the treatment course, transitioning from an initial parenteral dose to a long-term oral regimen. This protocol determines the appropriate method for correct and consistent use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Disys

Evidence for use in High Blood Pressure (Hypertension)

Research examining Disys (Valsartan) was studied for persistently elevated arterial pressure in large-scale, long-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how blood pressure values change over time in both adults and, in separate trials, in children and adolescents. These large trials monitored thousands of people over several years. The main focus of these studies was to evaluate outcomes monitoring physiological strain or stress, including the rate and time it took for cardiovascular events, such as stroke or heart attack, to be observed in the study populations. Studies also tracked the incidence of new-onset type 2 diabetes. Findings describe patterns observed in the studies related to these major outcomes. Research highlights changes measured during the study period for both the upper and lower blood pressure readings.

Evidence for use in Chronic Heart Failure

Disys was studied for chronic heart failure in a foundation of large, randomized trials. This research examined outcomes related to systemic or functional imbalance and included studies conducted over defined time intervals. These trials included comparisons to a placebo or other heart failure medications. Studies explored the rates of death from all causes and, specifically, cardiovascular death. Research examined the measured frequency of hospitalization for heart failure, an outcome describing episodic or acute changes. Findings describe patterns observed in the studies related to these severe outcomes and reported how heart function evolved in the observed populations.

What is Still Under Scientific Review or Uncertain

While a robust evidence base exists for the core indications, several aspects remain under scientific review. For instance, comparative evidence is lacking for all possible long-term combinations with every other cardiovascular medicine. The results apply only to the populations studied, and data for certain ethnic groups or individuals with very specific, rare comorbidities remain limited. Evidence quality varies across studies, particularly when moving from large RCTs to smaller subgroup analyses.

Frequently Asked Questions (FAQ)

Common questions about Disys (FAQ)


Q: Is Disys the same kind of medication as [Commonly known competitor/class of drug]?

Disys contains the active ingredient Valsartan, which belongs to a class of medications known as Angiotensin II Receptor Blockers (ARBs). This classification is based on its specific molecular action, which is distinct from other major classes of medication used to manage blood pressure or heart conditions.


Q: How long does it usually take for a person to notice the effects of Disys?

According to the official product information for treating high blood pressure, the blood pressure-lowering effect is typically substantial within two weeks of starting treatment. The full or maximal effect is generally reached after approximately four weeks of daily use. Monitoring by a healthcare professional is typically used to confirm the therapeutic effect.


Q: Does Disys typically cause weight gain?

Official adverse reaction tables from clinical trial data do not consistently list weight gain as a common or frequently observed side effect during treatment with Disys (Valsartan) monotherapy for high blood pressure. Body weight concerns are typically addressed through consultation with a healthcare provider.


Q: Why is Disys only available by prescription?

Disys is classified as a prescription-only medication because its use is associated with potentially serious risks, requiring strict professional monitoring. Key safety constraints include the Boxed Warning for Fetal Toxicity and the need to regularly monitor blood pressure, kidney function, and blood potassium levels.


Q: Do I need to change my diet while I am using Disys?

Disys may carry a risk of elevated blood potassium levels, a condition called hyperkalemia. For this reason, regulatory documents state the importance of avoiding potassium supplements or certain salt substitutes that contain potassium due to the interaction risk.


Q: Is Disys considered a controlled substance?

No, Disys (Valsartan) is not classified as a federally controlled substance by the US Drug Enforcement Administration (DEA) or other major government bodies. Its regulatory classification relates to its prescription status based on the drug's mechanism and safety profile.


Q: Are there any specific foods or drinks to avoid while taking Disys?

Regulatory documents describe the interaction risk with potassium supplements and salt substitutes that contain potassium, which are associated with the potential for high potassium levels (hyperkalemia). No specific warnings are broadly issued for other foods or drinks.


Q: Can elderly people safely use Disys?

Official regulatory documents indicate that no overall difference in safety or effectiveness has been specifically identified between elderly patients and younger adults. However, a general principle is that greater sensitivity in some older individuals cannot be entirely ruled out, and their response is often monitored by health professionals.


Q: How long can a person expect to be on Disys treatment?

Disys is indicated for treating chronic, long-term conditions like high blood pressure and heart failure. Official research evidence, which includes clinical trials that monitored patients for several years, suggests that treatment is typically intended for long-term therapy to manage these conditions.


Q: Can a person stop taking Disys suddenly?

Stopping a blood pressure medication like Disys abruptly can sometimes lead to a rapid increase in blood pressure, potentially causing an adverse health event. If an individual stops taking the medication, monitoring by a healthcare professional is important to manage blood pressure.


Q: What kind of warnings are listed on the package insert for Disys?

The most serious safety constraint is a Boxed Warning for Fetal Toxicity, which states that use during the last two trimesters of pregnancy can cause severe injury or death to a developing fetus. Other serious warnings relate to the potential for severe allergic reactions (angioedema) and kidney problems.


Q: Is Disys safe to use before an upcoming surgery?

The official product information mentions caution when Disys is used in patients undergoing surgery or dialysis. This is because the medication can increase the risk of developing symptomatic low blood pressure (hypotension) during these procedures.


Q: Why do some people report having trouble sleeping after starting Disys?

While not listed as a common side effect, insomnia (difficulty sleeping) has been reported in post-marketing experience with Disys (Valsartan). This indicates that it has been infrequently observed by some individuals outside of controlled clinical trials.


Q: Are there any known issues combining Disys with herbal products?

Regulatory sources generally advise that the safety and interaction profile of combining Disys with many herbal remedies and supplements are unknown. These products are not typically subject to the same rigorous interaction testing as prescription drugs.


Q: Can Disys cause changes in mood or anxiety levels?

Anxiety is listed as a rare or infrequent adverse event that has been reported in clinical trials or through post-marketing experience with Valsartan. Any concerning changes in mood or anxiety are typically reported to a healthcare provider for review.


Q: Is Disys used to treat any conditions other than its main approval?

The FDA-approved uses for Disys include the treatment of high blood pressure, heart failure (specifically NYHA Class II–IV), and improving survival outcomes following a myocardial infarction (heart attack). These are the only conditions officially recognized in regulatory labeling.


Q: What are the rules regarding driving or operating machinery while taking Disys?

Official patient information advises caution when driving or operating machinery. This warning is based on the fact that common side effects of Disys include dizziness and fatigue, which may temporarily affect an individual’s ability to perform these tasks safely.


Q: Does Disys interact with alcohol?

Regulatory documents indicate that alcohol consumption may have additive effects with Disys in lowering blood pressure. This combination can increase the risk of adverse effects like excessive low blood pressure (hypotension) and associated symptoms such as dizziness or fainting.


Q: What is the half-life or duration of effect for Disys?

The active ingredient, Valsartan, has an average elimination half-life of approximately 6 hours in the body. However, the blood pressure-lowering effect is designed to persist for 24 hours, supporting its once-daily dosing regimen.


Q: Does Disys require any special monitoring or regular blood tests?

Yes, official prescribing information advises that monitoring of renal function (kidney health) and serum potassium levels is recommended during treatment. This monitoring is important to detect and manage potential changes in kidney function or electrolyte balance.


Q: Is the brand name Disys the only version available?

The active ingredient, Valsartan, is available as the branded product Disys and is also widely available as FDA-approved generic versions from various manufacturers. Generic versions contain the same active ingredient and meet the same regulatory standards for safety and effectiveness.


Q: Why are there warnings about certain mental health conditions and Disys?

Disys can interact with Lithium, a medication commonly used to treat certain mental health conditions. Official warnings exist because co-administration can increase the concentration of Lithium in the blood, potentially leading to toxic levels.


Q: What is the risk of having an allergic reaction to Disys?

While rare, serious allergic reactions, including angioedema (swelling of the face, lips, or throat), have been documented in post-marketing reports. The medication is contraindicated for anyone with a known hypersensitivity to its components.


Q: How soon after stopping Disys will it be completely out of the system?

The active ingredient, Valsartan, is effectively cleared from the body approximately 30 hours after the last dose, based on its elimination half-life of 6 hours. This means the therapeutic effects begin to diminish soon after the last dose.


Q: Can Disys cause stomach upset or digestive issues?

According to clinical trial data, diarrhea and abdominal pain have been reported as side effects. These effects occurred at rates similar to or slightly higher than those seen in patients taking placebo.


Q: Is Disys safe to take with common vitamins or mineral supplements?

Official information explicitly warns against co-administration with Potassium supplements. Official guidance emphasizes the importance of sharing information with a doctor about all vitamins and mineral supplements being taken, as not all possible combinations have been specifically tested for interactions.


Q: What is the maximum duration of use studied for Disys?

The effectiveness and long-term safety of Disys for its approved chronic indications were established in major clinical trials. These studies involved monitoring patients for periods of several years to track long-term cardiovascular outcomes.


Q: What should a patient do if they experience a severe side effect from Disys?

Regulatory guidance advises patients to immediately stop taking the medication and seek emergency medical attention if they notice signs of a serious reaction, such as swelling of the face, lips, or throat (angioedema) or difficulty breathing.

How should Disys be stored and disposed of?

The official regulatory guidelines for Disys (Valsartan) storage and disposal are specific to its form to ensure stability and safety.

Storage Requirements

Form Temperature Requirement Handling Restriction
Tablets Controlled Room Temp (20 C-25 C) Protect from moisture.
Oral Suspension Refrigerated (2 C-8 C) Do not freeze. Discard 30 days after opening.

Both forms must be kept in the original, tightly closed container and protected from moisture. All medication must be kept out of the sight and reach of children.

️ Disposal Instructions

Unused or expired Disys must be disposed of according to local pharmaceutical waste requirements. Regulatory documents state that the product should not be disposed of via household trash or wastewater to prevent the active substance from entering the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Disys found in:

A-Z Index: